Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories.
Pepe F, Venetis K, Cursano G, Frascarelli C, Pisapia P, Vacirca D, Scimone C, Rappa A, Russo G, Mane E, Pagni F, Castellano I, Troncone G, Angelis C, Curigliano G, Guerini-Rocco E, Malapelle U, Fusco N. Pepe F, et al. Among authors: fusco n. Pharmacogenomics. 2024 Feb;25(3):161-169. doi: 10.2217/pgs-2023-0238. Epub 2024 Mar 5. Pharmacogenomics. 2024. PMID: 38440825
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study.
Guerini-Rocco E, Hodi Z, Piscuoglio S, Ng CK, Rakha EA, Schultheis AM, Marchiò C, da Cruz Paula A, De Filippo MR, Martelotto LG, De Mattos-Arruda L, Edelweiss M, Jungbluth AA, Fusco N, Norton L, Weigelt B, Ellis IO, Reis-Filho JS. Guerini-Rocco E, et al. Among authors: fusco n. J Pathol. 2015 Oct;237(2):166-78. doi: 10.1002/path.4566. Epub 2015 Jul 29. J Pathol. 2015. PMID: 26011570 Free PMC article.
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations.
Guerini-Rocco E, Piscuoglio S, Ng CK, Geyer FC, De Filippo MR, Eberle CA, Akram M, Fusco N, Ichihara S, Sakr RA, Yatabe Y, Vincent-Salomon A, Rakha EA, Ellis IO, Wen YH, Weigelt B, Schnitt SJ, Reis-Filho JS. Guerini-Rocco E, et al. Among authors: fusco n. J Pathol. 2016 Apr;238(5):677-88. doi: 10.1002/path.4691. J Pathol. 2016. PMID: 26806567 Free PMC article.
Circulating and tissue biomarkers in early-stage non-small cell lung cancer.
Fumagalli C, Bianchi F, Raviele PR, Vacirca D, Bertalot G, Rampinelli C, Lazzeroni M, Bonanni B, Veronesi G, Fusco N, Barberis M, Guerini-Rocco E. Fumagalli C, et al. Among authors: fusco n. Ecancermedicalscience. 2017 Jan 31;11:717. doi: 10.3332/ecancer.2017.717. eCollection 2017. Ecancermedicalscience. 2017. PMID: 28194229 Free PMC article.
CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report.
Del Gobbo A, Fusco N, Barella M, Ercoli G, Sciarra A, Palleschi A, Pagni F, Marchiò C, Papotti M, Ferrero S. Del Gobbo A, et al. Among authors: fusco n. Cell Oncol (Dordr). 2018 Dec;41(6):687-691. doi: 10.1007/s13402-018-0401-9. Epub 2018 Sep 4. Cell Oncol (Dordr). 2018. PMID: 30182340 Free article.
Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up.
Invernizzi M, Corti C, Lopez G, Michelotti A, Despini L, Gambini D, Lorenzini D, Guerini-Rocco E, Maggi S, Noale M, Fusco N. Invernizzi M, et al. Among authors: fusco n. BMC Cancer. 2018 Sep 29;18(1):935. doi: 10.1186/s12885-018-4851-2. BMC Cancer. 2018. PMID: 30268112 Free PMC article.
327 results